Jens Huober - Abteilung für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm

基本信息

浏览量：275

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 791 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PO5-25-12: CDH1 Mutations Predict Resistance to Neoadjuvant Taxane Therapy

Cancer Researchno. 9_Supplement (2024): PO5-25

引用0浏览0引用

Figure S5 from Paclitaxel Plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Hans Wildiers,Anne Armstrong,Eveline Cuypere,Florence Dalenc, Luc Dirix, Steve Chan,Frederik Marmé,Carolina P. Schröder,Jens Huober,François P. Duhoux, Peter Vuylsteke,Agnes Jager,Étienne Brain, Sherko Kümmel,Zsuzsanna Pápai,C. Willemien Menke-van der Houven van Oordt,Luca Perjesi,Christian Müeller,Chrystelle Brignone, Frédéric Triebel

openalex（2024）

引用0浏览0引用

Figure S1 from Paclitaxel Plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Hans Wildiers,Anne Armstrong,Eveline Cuypere,Florence Dalenc, Luc Dirix, Steve Chan,Frederik Marme,Carolina P. Schröder,Jens Huober,Francois P. Duhoux, Peter Vuylsteke,Agnes Jager,Etienne Brain, Sherko Kuemmel,Zsuzsanna Pápai,Catharina Willemien Menke-van der Houven van Oordt,Luca Perjesi,Christian Mueller,Chrystelle Brignone, Frederic Triebel

openalex（2024）

引用0浏览0引用

Figure S6 from Paclitaxel Plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Hans Wildiers,Anne Armstrong,Eveline Cuypere,Florence Dalenc, Luc Dirix, Steve Chan,Frederik Marmé,Carolina P. Schröder,Jens Huober,François P. Duhoux, Peter Vuylsteke,Agnes Jager,Étienne Brain, Sherko Kümmel,Zsuzsanna Pápai,C. Willemien Menke‐van der Houven van Oordt,Luca Perjesi,Christian Müeller,Chrystelle Brignone, Frédéric Triebel

openalex（2024）

引用0浏览0引用

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 9 (2024): 987-993

引用0浏览0WOS引用

Abemaciclib Plus a Nonsteroidal Aromatase Inhibitor As Initial Therapy for HR+, HER2- Advanced Breast Cancer: Final Overall Survival Results of MONARCH 3

Annals of oncology official journal of the European Society for Medical Oncologyno. 12 (2024): 1202-1204

引用0浏览0WOS引用

CMR Reveals Myocardial Damage from Cardiotoxic Oncologic Therapies in Breast Cancer Patients

Johannes Kersten,Visnja Fink,Maria Kersten, Lisa May,Samuel Nunn,Marijana Tadic,Jens Huober,Inga Bekes,Michael Radermacher,Vinzenz Hombach,Wolfgang Rottbauer,Dominik Buckert

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGINGno. 2 (2024): 225-235

引用0浏览0WOS引用

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer (EBC): Update 2024

Breast Careno. 3 (2024): 165-182

引用0浏览0WOS引用

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

BREAST CARE (2024)

引用0浏览0引用

Figure S4 from Paclitaxel Plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Hans Wildiers,Anne Armstrong,Eveline Cuypere,Florence Dalenc, Luc Dirix, Steve Chan,Frederik Marme,Carolina P. Schröder,Jens Huober,Francois P. Duhoux, Peter Vuylsteke,Agnes Jager,Etienne Brain,Sherko Kuemmel,Zsuzsanna Pápai,Catharina Willemien Menke-van der Houven van Oordt,Luca Perjesi,Christian Mueller,Chrystelle Brignone, Frederic Triebel

openalex（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn